PhRMA Continues Call For Downgrade In Thai Trade Status
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Once again the U.S. pharmaceutical industry has requested the U.S. government to downgrade Thailand's trade status due to intellectual property rights violations. The downgrade would subject Thai exports to higher tariffs and a loss of tax privileges in the U.S